HF
INAB icon

HRT Financial’s IN8bio INAB Stock Holding History

HRT Financial’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,913
Closed -$34K – 4231
2025
Q4 		$34K Buy
+14,913
New +$28.4K ﹤0.01% 2925
2024
Q4 		– Sell
-375
Closed -$3K – 2797
2024
Q3 		$3K Buy
375
+15
+4% +$272 ﹤0.01% 2287
2024
Q2 		$9K Buy
+360
New +$11.6K ﹤0.01% 2006

Other funds holding INAB

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

HRT Financial's INAB Position: Q1 2026 in Review

HRT Financial sold out of IN8bio (INAB) in Q1 2026, closing a stake of 14,913 shares — an estimated $34K sold.

HRT Financial first reported a position in INAB in Q2 2024 and held it in 3 quarters. The position peaked at $34K in Q4 2025. 19 funds tracked by Wall St. Rank hold INAB as of Q1 2026.

  • HRT Financial reported no remaining IN8bio position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 14,913 IN8bio shares in Q1 2026, an estimated $34K.
  • HRT Financial first reported a position in IN8bio in Q2 2024 and held it in 3 quarters.
  • HRT Financial's IN8bio position peaked at $34K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held IN8bio as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.